The first series of questions at tomorrow's conference call will probably come from Zacks' senior bio-tech analyst, Jason Napadano.

Mr. Napadano has already stated that he would have an updated article on the company after the conference call. I would expect the article will be released early next week.

p.s. If anyone here is going to ask Gerald questions tomorrow you may want to ask him if there is any significance to be attached to Amarantus opening its European office in Geneva where Roche is headquartered.